Cargando…

Niacin Ameliorates Neuro-Inflammation in Parkinson’s Disease via GPR109A

In this study, we used macrophage RAW264.7 cells to elucidate the molecular mechanism underlying the anti-inflammatory actions of niacin. Anti-inflammatory actions of niacin and a possible role of its receptor GPR109A have been studied previously. However, the precise molecular mechanism of niacin’s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giri, Banabihari, Belanger, Kasey, Seamon, Marissa, Bradley, Eric, Purohit, Sharad, Chong, Raymond, Morgan, John C., Baban, Babak, Wakade, Chandramohan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770365/ https://www.ncbi.nlm.nih.gov/pubmed/31540057 http://dx.doi.org/10.3390/ijms20184559

Ejemplares similares

Niacin Enhancement for Parkinson’s Disease: An Effectiveness Trial
por: Chong, Raymond, et al.
Publicado: (2021)

Low-Dose Niacin Supplementation Improves Motor Function in US Veterans with Parkinson’s Disease: A Single-Center, Randomized, Placebo-Controlled Trial
por: Wakade, Chandramohan, et al.
Publicado: (2021)

Low-dose niacin supplementation modulates GPR109A, niacin index and ameliorates Parkinson’s disease symptoms without side effects
por: Wakade, Chandramohan, et al.
Publicado: (2015)

Niacin and Butyrate: Nutraceuticals Targeting Dysbiosis and Intestinal Permeability in Parkinson’s Disease
por: Karunaratne, Tennekoon B., et al.
Publicado: (2020)

Upregulation of GPR109A in Parkinson’s Disease
por: Wakade, Chandramohan, et al.
Publicado: (2014)

Structural and Energetic Insights Into the Interaction of Niacin With the GPR109A Receptor
por: Adepu, Kiran Kumar, et al.
Publicado: (2021)

The Role of GPR109a Signaling in Niacin Induced Effects on Fed and Fasted Hepatic Metabolism
por: Geisler, Caroline E., et al.
Publicado: (2021)

Niacin Improves Intestinal Health through Up-Regulation of AQPs Expression Induced by GPR109A
por: Liu, Shilong, et al.
Publicado: (2022)

Niacin Alleviates Dairy Cow Mastitis by Regulating the GPR109A/AMPK/NRF2 Signaling Pathway
por: Guo, Wenjin, et al.
Publicado: (2020)

Inflammation and JNK's Role in Niacin-GPR109A Diminished Flushed Effect in Microglial and Neuronal Cells With Relevance to Schizophrenia
por: Ansarey, Sabrina H.
Publicado: (2021)

Involvement of the Niacin Receptor GPR109a in the Local Control of Glucose Uptake in Small Intestine of Type 2 Diabetic Mice
por: Wong, Tung Po, et al.
Publicado: (2015)

Niacin protects against abdominal aortic aneurysm formation via GPR109A independent mechanisms: role of NAD(+)/nicotinamide
por: Horimatsu, Tetsuo, et al.
Publicado: (2019)

GPR109A and Vascular Inflammation
por: Chai, Joshua T., et al.
Publicado: (2013)

Parabacteroides distasonis ameliorates insulin resistance via activation of intestinal GPR109a
por: Sun, Yonggan, et al.
Publicado: (2023)

Niacin exacerbates β cell lipotoxicity in diet-induced obesity mice through upregulation of GPR109A and PPARγ2: Inhibition by incretin drugs
por: Zhang, Xiaojing, et al.
Publicado: (2022)

GPR109A activation and aging liver
por: Jadeja, Ravirajsinh N., et al.
Publicado: (2019)

Colon-Targeted Trans-Cinnamic Acid Ameliorates Rat Colitis by Activating GPR109A
por: Kang, Changyu, et al.
Publicado: (2022)

Ketone Body 3‐Hydroxybutyrate Ameliorates Atherosclerosis via Receptor Gpr109a‐Mediated Calcium Influx
por: Zhang, Shu‐jie, et al.
Publicado: (2021)

Amelioration of bleomycin-induced lung fibrosis in hamsters by dietary supplementation with taurine and niacin: biochemical mechanisms.
por: Giri, S N, et al.
Publicado: (1994)

The dimensionality of fatigue in Parkinson’s disease
por: Chong, Raymond, et al.
Publicado: (2018)

Niacin Ameliorates Lipid Disturbances due to Glucocorticoid Administration in Rats
por: Safaei, Niloofar, et al.
Publicado: (2012)

Emerging roles of GPR109A in regulation of neuroinflammation in neurological diseases and pain
por: Taing, Kyle, et al.
Publicado: (2022)

Niacin‐mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination
por: Bolino, Alessandra, et al.
Publicado: (2016)

Loss of GPR109A/HCAR2 induces aging-associated hepatic steatosis
por: Jadeja, Ravirajsinh N., et al.
Publicado: (2019)

Niacin in Maize
por: Burkholder, Paul R., et al.
Publicado: (1944)

GPR109A mediates the effects of hippuric acid on regulating osteoclastogenesis and bone resorption in mice
por: Chen, Jin-Ran, et al.
Publicado: (2021)

Nicotinic Acid Receptor GPR109A Is Down-Regulated in Human Macrophage-Derived Foam Cells
por: Chai, Joshua T., et al.
Publicado: (2013)

β-Hydroxybutyrate Suppresses Lipid Accumulation in Aged Liver through GPR109A-mediated Signaling
por: Lee, A Kyoung, et al.
Publicado: (2020)

Exploring GPR109A Receptor Interaction with Hippuric Acid Using MD Simulations and CD Spectroscopy
por: Bhandari, Dipendra, et al.
Publicado: (2022)

The Specificity and Broad Multitarget Properties of Ligands for the Free Fatty Acid Receptors FFA3/GPR41 and FFA2/GPR43 and the Related Hydroxycarboxylic Acid Receptor HCA2/GPR109A
por: Bisenieks, Egils, et al.
Publicado: (2021)

Tributyrin Attenuates Metabolic and Inflammatory Changes Associated with Obesity through a GPR109A-Dependent Mechanism
por: Sato, Fabio Takeo, et al.
Publicado: (2020)

GPR109A alleviate mastitis and enhances the blood milk barrier by activating AMPK/Nrf2 and autophagy
por: Guo, Wenjin, et al.
Publicado: (2021)

Melatonin alleviates titanium nanoparticles induced osteolysis via activation of butyrate/GPR109A signaling pathway
por: Wu, Yanglin, et al.
Publicado: (2021)

Design and Evaluation of Niacin Microspheres
por: Maravajhala, Vidyavathi, et al.
Publicado: (2009)

Niacin in the Treatment of Hyperlipidemias in Light of New Clinical Trials: Has Niacin Lost its Place?
por: Zeman, Miroslav, et al.
Publicado: (2015)

Niacin Alternatives for Dyslipidemia: Fool’s Gold or Gold Mine? Part II: Novel Niacin Mimetics
por: Goel, Harsh, et al.
Publicado: (2016)

Niacin Alternatives for Dyslipidemia: Fool’s Gold or Gold Mine? Part I: Alternative Niacin Regimens
por: Dunbar, Richard L., et al.
Publicado: (2016)

Glio‐ and neuro‐protection by prosaposin is mediated by orphan G‐protein coupled receptors GPR37L1 and GPR37
por: Liu, Beihui, et al.
Publicado: (2018)

The mechanism and mitigation of niacin-induced flushing
por: Kamanna, V S, et al.
Publicado: (2009)

Anti-inflammatory effects of BHBA in both in vivo and in vitro Parkinson’s disease models are mediated by GPR109A-dependent mechanisms
por: Fu, Shou-Peng, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_087a89b8mce8ojmmjugvfl5epv